Filter posts

BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, …

How Will Brexit Impact Patients and Biotech Innovation?

The clock is beginning to run out for British Parliament to finalize a Brexit plan. …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an …

BIO Hosts Embassy Briefing on International Economic Development

Last week BIO hosted embassy representatives from over 25 countries to debut a new report …

It Starts with One—Presentation at BIO 2018 Leads to International Agreement

A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel …

#MakeHistory: Highlighting History | South Korea

With the conclusion of the Winter Olympics earlier this year in South Korea, the pomp …

#MakeHistory: Highlighting History | Hong Kong’s New Listing Regime

Recent announcements that the Hong Kong Stock Exchange (HKEX) plans to allow the listing of …

#MakeHistory: Highlighting History | Taiwan

As one of the many economies inspired by the 1980s Biotech Revolution, Taiwan has adapted …